Mineralocorticoid Receptors in Myocardial Infarction
- 1 December 2009
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 54 (6) , 1211-1212
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial InfarctionHypertension, 2009
- Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ DamageCirculation, 2005
- Origin of Aldosterone in the Rat HeartEndocrinology, 2004
- Direct and Indirect Effects of Aldosterone on Cyclooxygenase-2 and Interleukin-6 Expression in Rat Cardiac Cells in Culture and after Myocardial InfarctionEndocrinology, 2004
- Aldosterone Plays a Pivotal Role in the Pathogenesis of Thrombotic Microangiopathy in SHRSPJournal of the American Society of Nephrology, 2003
- Spironolactone increases integrin β3 gene expression in kidney and heart muscle cellsMolecular and Cellular Endocrinology, 2002
- Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- Cardiac aldosterone production and ventricular remodelingKidney International, 2000
- Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance levelKidney International, 1992
- Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuriesKidney International, 1991